Background
Jaroslaw Jozef Spychala was born on January 21, 1960 in Sierakow, Poland. Son of Jozef and Walentyna (Nitschke) Spychala.
Jaroslaw Jozef Spychala
Jarek Spychala, School period
Jaroslaw Spychala, School period
Jaroslaw Spychala, College
Jaroslaw Spychala, University
Jaroslaw Spychala, Ph.D. Student
Jaroslaw Spychala, Postdoctorate
Jaroslaw Spychala, Career
AMU Department of Chemistry, Poznan
AMU Students, the Teaching of Chemistry
Jaroslaw Spychala, Cape Canaveral, Fl
Jaroslaw Spychala, NASA Rocket Garden
Daphne Santiago and Lenong Wang-Allison
Jaroslaw Spychala, Jeol JNM-GX 270
Denise, Jarek, Lenong, and Daphne, Underground Atlanta
Amy, David, Jarek, Bob, Krisztina, and Tibor, San Francisco, CA
Jaroslaw Spychala, The SC Membership Card
Jaroslaw Spychala, ACS Membership Card
Jaroslaw Spychala, NYAS Membership Card
NYAS Membership Certificate Replica
AAAS Membership Certificate Replica
Jarek Spychala, School period
Jaroslaw Spychala, School period
Jaroslaw Spychala, College
Jaroslaw Spychala, University
NYAS Membership Certificate Replica
Jaroslaw Spychala, Career
Jaroslaw Spychala, Postdoctorate
Jaroslaw Spychala, Cape Canaveral, Fl
AMU Department of Chemistry, Poznan
AMU Students, the Teaching of Chemistry
Jaroslaw Spychala, NASA Rocket Garden
Daphne Santiago and Lenong Wang-Allison
Jaroslaw Spychala, Jeol JNM-GX 270
Jaroslaw Spychala, The SC Membership Card
Jaroslaw Spychala, Ph.D. Student
Denise, Jarek, Lenong, and Daphne, Underground Atlanta
Amy, David, Jarek, Bob, Krisztina, and Tibor, San Francisco, CA
Jaroslaw Spychala, ACS Membership Card
Jaroslaw Spychala, NYAS Membership Card
AAAS Membership Certificate Replica
Mother Walentyna Spychala
Father Jozef Spychala
Grandmother Stanislawa Nitschke
InterFACE, Washington, DC, USA
Marek, Agnieszka, David, Jarek, and Arvind, GSU Boykins Team
Friar Boguslaw Kochaniewicz Pilgrimage to Czestochowa
With Dr. Everett Boyce Yosemite NP
(One N-methyl- and 4-substituted 2-imidazolines are descri...)
One N-methyl- and 4-substituted 2-imidazolines are described. Fluorene bisimidazolines were obtained in good yield (64–92%), starting from 2,7-dicyanofluorene and ammonium sulfide. In a two-step...
https://link.springer.com/article/10.1007/s00706-006-0516-y
Jaroslaw Jozef Spychala was born on January 21, 1960 in Sierakow, Poland. Son of Jozef and Walentyna (Nitschke) Spychala.
Baccalaureate (examination for the secondary-school certificate in Polish, Maths, Chemistry, and French), Miedzychod High School, Math-physics Profiled Liceum, 1979. Master of Science, Adam Mickiewicz University, 1984. Doctor of Philosophy, Adam Mickiewicz University, 1991. Postdoctorate, Postdoctoral Programs at Georgia State University, 1994. Independent Scholar, Professional Development at Adam Mickiewicz University up to 2006 (scientist with early independence before obtaining a professorship).
Assistant Professor, Adam Mickiewicz University, Poznan, since 1994 (cutting edge research and curtail scientific career in 2006, wrongful dismissal, discriminatory and retaliatory termination, public and a private wrong, and other AMU wicked deeds). Postdoctoral Associate, Georgia State University, 1991-1994 (9 multidisciplinary papers and several patents, excellent analytical and influential skills, challenging position, excellent links with national and international research networks, and tangible results for the benefit of society). He was strengthening his research activities in the synthesis of polycatinic compounds in an interdisciplinary research project. In the role of result driven PDA (pragmatic and always with an eye on quality and safety) he had a key task in the Boykin’s project team, working with an international companionship, closely together with the Wilson’s Center for Biotechnology and Drug Design. He spent the majority of his time doing experimental work. In addition he performed literature studies, wrote project updates and reports, assisted in 2-3 weekly departmental seminars by leading scientists from around the world at the forefront of chemical research, and attended meetings (project reporting and presentation of results on internal project meetings) in a collaborative environment, with external partners: Tidwell’s Group of Scientists (Department of Pathology, School of Medicine, The University of North Carolina at Chapel Hill, NC), Schinazi’s Group working in the field of biochemical pharmacology (The School of Medicine, Emory University, Atlanta, GA and Veterans Affaires Medical Center, Deacatur, GA), and scientists of other disciplines in the field.
As a postdoctoral associate (PDA), he was able to broaden his research expertise, build associations with established researchers, and strengthen his publication record, thereby enhancing his future individual independent research. He had the opportunity to make significant contributions to natural sciences, the University, faculty researchers, and graduate students (Daphne Santiago, Ph.D., Lenong Wang-Allison, M.S., and Sherrie Thomas; there are appropriate acknowledgements in their doctoral and master’s dissertations) in order to enhance cross-fertilization. At GSU, his skills, dedication, and ambition help each other change lives for the better. In exchange, the vibrant and international research center offered him an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development. He demonstrated ability to act in a decisive, urgent, and committed fashion to support the University.
Jaroslaw Spychala joined the laboratory of Dr. D.W. Boykin in April 1991 after graduating with a Ph.D. from the AMU Department of Chemistry. The main focus of his research has been to synthesize new potential anti-AIDS agents to advance small-molecule drug discovery programs. For this he employed several methods, including own methodology (relevant work experience and scientific workbench; some independent, non-course laboratory experience to achieve breakthroughs in amidine research) in the Pinner Synthesis. They led to new bisamidine polycationic drugs that selectively interact with nucleic acids. Neidle’s Group of Crystallographers (co-authors from the Institute of Cancer Research, Sutton, Surrey, UK) determined the X-ray crystal structure of furamidine complex to probe the existence of DNA binding in the solid state and provided a detailed structural description of it. The mechanism of DNA minor-groove binding of diamidines is highly probable. Expert understanding of medicinal chemistry concepts in the application of structure based design, physicochemical, biochemical, and pharmacological principles have been applied to drug discovery.
His many outstanding performances (particular knowledge) published in high quality journals: Spychala Reaction I (cyclic amidines from nitriles), Spychala Reaction II (simple amidines from thioamides and zinc ammoniates), Spychala Reaction III (several protonation reactions and reactivity including zwitterionic monomethylamidine formation), Spychala Rearrangement (H2S molecule migration in the thioamide-nitrile system), newfound bonds, correlations, selectivity, and other individual valuable contributions to organic chemistry and medicinal drug discovery. It was a single-handed effort on his part. Just look at the attached dozen top publications described the pioneering research!
(The reaction of thioamides with the R1R2N–ZnCl ammoniates...)
(One N-methyl- and 4-substituted 2-imidazolines are descri...)
A fire and lighting of the NEW Paschal candle kindled and blessed by the priest, The Service of Light, ‘Light of Christ’ (Christ is ‘light and life’ throughout the coming year). The NEW fire symbolizes the light of salvation and hope that God brought into the world through Christ’s Resurrection, dispelling the darkness of sin and death. Those who have received the ‘Light of Christ’ have an opportunity to make a NEW life for themselves. This is what a person can gain from the Christianity (loving and approachable God) and its beliefs.
The reforms are not going far enough to view the future with optimism. There is cause for concern: wrongdoing of the judiciary (Judges as Criminals?), incompetent and mercenary judges and other public servants, wrong law interpretations, lawlessness (alcoholism, falseness, fraudulence, juvenile delinquency, juvenile prostitution, robbery and assault, vagrancy, vandalism, white slavery), mendacity, officialdom, incapacity, no right democracy as yet (half-democratic Poland), liberal philosophies of law, constitution violation, constitutional disorder - rule hierarchy gross negligence (including EEC rules).
‘To commit perjury is the equal of baseness and villainy’, ‘Neither love nor mercy for the wicked persons’, ‘Judicature is a protective agent for democratic values. Law must serve justice’, ‘The real face of Polish democracy: legal makeshift, bad quality of judiciary, and logrolling of functionaries-public’, ‘Criminal mobbing and ganging up in academe, essay question’, and ‘Writ of Supervisory Control required by law’ (Jaroslaw Jozef Spychala).
Quotations:
‘We should all think in terms of worldviews (as fundamental orientation of the heart)’ (James W. Sire), ‘The goal of life is to grow in character, in Christ likeness’ (Rick Warren), ‘The LORD loves justice, and he will not abandon his godly ones. They will be kept safe forever, but the descendants of wicked people will be cut off’ (Psalm 37:28), ‘Truth and justice are not essential to the foundation of any one’s government’ (Bob Culver).
‘La beauté est une intarissable source de joie pour qui sait la découvrir / Beauty is an inexhaustible source of joy for who knows how to discover it’ (A. Carrel), ‘Partout il y a des merveilles, l’art consiste à les trouver’ (Melati de Java), ‘Ne laisse passer aucune opportunité pour dire un mot aimable / Never lose a chance of saying a kind word’ (W. Thackeray), ‘Si tu possèdes beaucoup, donne de ton bien; si tu possèdes peu donne de ton cœur / If you have much, give of your wealth; if you have little, give of your heart’ (Arabic Proverb), ‘Donne avant que l’on te demande; ce qui était demandé n’est donné qu’à moitié’ (Rückert), ‘N’attendons pas demain: Cueillons dès aujourd’hui les roses de la vie / Live, don’t wait until tomorrow to pick the roses of life’ (Pierre de Ronsard), ‘Etre heureux est le plus sûr moyen d’approcher la bonté’ (E. O’Neill).
New York Academy of Sciences (1997), Srs. Coalition (Washington 1994), Polish Fishing Union (1987), Polish Chemical Society (1986), American Association for the Advancement of Science (2002), and American Chemical Society (2006).
1994 Member, Washington, D.C., Metro Office: 11166 Main Street, Suite 302, Fairfax, Virginia 22030, Phone (703) 591-0663.
The Seniors Coalition , United States
2002 Member, 1200 New York Avenue, NW, Washington, DC 20005 U.S.A, Fast Fax +1 202-842-1065.
American Association for the Advancement of Science , United States
2006 Member, PO Box 82229, Columbus, OH, 43202-2229, Phone: (800) 333-9511 or (614) 447-3776, Fax (614) 447-3891.
American Chemical Society , United States
1997 Active Member, 2 East 63rd Street, New York, NY 10021, Phone (212) 838-0230 or (800) 843-6927, Fax (212) 888-2894.
New York Academy of Sciences , United States
Creative and experienced professional with a real passion for drug discovery, the highly qualified synthetic organic chemist has a high degree of independence and proven track record of applying modern synthetic organic techniques in the preparation of complex organic molecules and development of novel synthetic methodologies. Brand-new discoveries are on his publications list. He investigated and explored new ideas, demonstrated proof of concept, and created new intellectual properties.
Strength of Character: A creative and strategic thinker, full of originality, high energy and self-motivated, honest, upright, right-thinking, self-aware, highly ambitious for personal success in organic chemistry and medicinal chemistry, gritty, diligent, and straight person, able to prioritize work on multiple projects and to work well in multi-disciplinary teams, strength of purpose, result-oriented, methodological in approach, extensive experience, reliability, and strong scientific background.
Physical Characteristics: Hazel (brown) eye color, medium-sized: height 170 cm, over 105 kilos in weight, and bald head.
Quotes from others about the person
He is a ‘beautiful brains’ of Polish sciences / Jest "pięknym umysłem" polskiej nauki (Newspaperwoman Natalia Mazur, Gazeta.pl Forum, Gazeta.pl Poznan).
Biking, biking trails, card games, cart-tracks, excursion into the country, fishing, forest trails, genealogy, historical sites, lakeside scenery, landscape pictures, music concerts, photography, postglacial remains, recreational activities, religiousness, sightseeing, tourism, traveling, walking, wildlife reserve (https://goo.gl/photos/HKT6iZVUMeV5pHM79).
St. Augustine (Our understanding of the dignity of the individual or the person originates with Christianity).
Anna Maria Anders in the Republic of Poland - London-born non-party politician concerned about national welfare, Senator, Secretary of State and other governmental posts, polyglot with three citizenships. She graduated from Bristol University with an honors degree in modern languages (fluent Polish, English, French, Spanish, Italian, and German), also a Boston University graduate (economics degree), Polonia active person, former UNESCO employee in Paris; other workplaces: Raytheon weaponry manufacturer (together with her deceased in 2007 husband, US Army Colonel Robert Alexander Costa) and petroleum industry. The woman senator has a passion for defense forces, patriotic and civic education, and strengthening lies with Poles throughout the world. She is an advocate of the military and veterans affairs (On Uhlan Days in Poznan, https://twitter.com/jjspychala/status/923503532258615296).
Jacques Prévert (‘Paroles’): ‘Est-il mort disparu ou bien encore vivant…’.
His Eminence Cardinal Zenon Grocholewski in the St. Peter and St. Paul Archcathedral Basilica - The Visitation of the Our Lady of Czestochowa Image Vigil and Farewell, the Baptism of Poland 1050th Anniversary Celebration in Poznan (04/15/2016). The solemn Marian procession took place through the streets from the Fara (Collegiate Parish Church) to the Cathedral on Cathedral Island. The notable guest (cardinal presbyter from 2011, cardinal deacon from 2001) was ordained a priest in Poznan in 1963. He is considered as one of the best experts on Canon Law. His bibliography surpasses 550 publications in 12 languages (https://photos.app.goo.gl/99a2LGDt5sonE6Px6 and https://goo.gl/photos/gHWNn3P9cvPfGhnp7).
Renata Zarebska, Christopher Pantillion, Paul Harwin, Bert Brandsma, Aleksandra Brzezowska, Aleksandra Fichna-Chelkowska, Maciej Markiewicz, Irena Santor, Zbigniew Wodecki, Reni Jusis, Jacek Leszek Mejer, Andrzej Tomasz Piaseczny, Dana Saga Tomaszewska, Michael Schönheit, Major Pawel Joks, Lukasz Rostkowski, Jan Adamczewski, Mieczyslaw Hryniewicz, Mieczyslaw Horszowski, Teresa Werner, Damian Holecki, Cabaret Masztalscy, Duo Fenix-Dwa Fyniki, Eugeniusz Witek, Marcin Daniec, Grzegorz Stasiak, Marcela Haladuda, Malgorzata Brodniewicz.
Acrobatic gymnastics, trampoline gymnastics, rowing, triathlon, marathon, beach volleyball, extreme water sports: hoverboard, jetpack, and flyboard® acrobatics; JBL Triathlon Sierakow, Tarpan acrobatic spectacles (A. Wozniak Team and Lajkonik - Association for Hippotherapy), Pro Hipico Bono Hippological Association, horse sports club ‘Morena Sierakow-Galowo’, Representative Cavalry Detachment in the colors of the Poznan 15th Uhlans Regiment (historical reenactments, horseshows, and contests), show jumping, free jumping and halter rating, equi-soccer, horseball, pony ride, pony trekking, harness race, cart rides, horse showmanship under the four oak trees (Sierakow Stud Farm - Herd of Stallions).
Ewa Bugdol - European Titleholder, Multiple Polish Champion from Rudy Raciborskie (WLKS Kmicic Czestochowa), proving her prowess as an all-round athlete, was able to claim the European title on the women’s podium with the Polish flag draped across her back (2016 Poznan ETU Challenge Ironman Triathlon European Championship). She achieved one of the greatest successes of her career. A formal ceremony in grand style was celebrated on Liberty Square, hence the ripple of applause in the big fan zone with stands. This sporting event well attended by triathletes from 38 countries and thousands of cheering loudly fans have promised a truly unforgettable experience (https://photos.app.goo.gl/z3M9xkTkKxcm1DXL2).
Bagpipe music, folk, modern dance, aerial dance, hip hop, disco polo, dance, pop rock, Mezo, Sondorgo, Piersi, Arete, Adonis, Swing Craze, Mitch & Mitch, Piekni i Mlodzi, Folk-Dixie-Band Wroclawianie, Chawira Band, Balkanica Express, Anna Beker Jazz Dance Studio, Dixie Company, Dixieland Crackerjacks, Jurad, Bobi, Gora Trolla, Ksinzoki, Song and Dance Company ‘Lany’, ArtVivat Orchestra, Lao Che, Grodziska Orkiestra Deta, The City of Poznan Orchestra, Air Force Representative Orchestra, Marching Band from Swarzedz, The Little Morellos (Wisienki), Robert Lukowski & Gryffon, Kosmokwaki, Mikano, Modelinka & Model MT, Beata i Marcin, Silesian Hits Stars, From Beyond the Corner Band (Zza Winkla), Jazzpolizei, Slawomir, Staropolanie-Wielkopolska, Bubliczki, Ulyana Ethno Quintet, Volver.
Rap music held a fascination for Jacek Leszek Mejer ‘Mezo’ in the mid-1990’s already. The Mezo’s creativity is a combination of positive hip hop and pop music. The lyrics are focused on public energy transmission. The first solo track ‘Swordplay’ was released in 1991 (on disc in 2002: Owal/Emcedwa ‘Episode II Rapnasty’). On the Polish music scene, the Mezo great success was achieved in the year 2003 by recording a debut album entitled ‘Mezokracja’ (UMC Records). In 2014 the released album ‘The Scenery after Battle’ has contained the following promotional singles: ‘The Only One’, ‘Anew’, and ‘A Holy Calm’. The author received the VIVA Comet Awards for: the 2009 Best Artist, Decade Hit (‘The Sacred’), and Artist of the Decade. His mission is to motivate people to strive for perfection, overcome their weaknesses, and improve their lives. Hence the marathon run, triathlon, and game of tennis are a stepping stone for him and restore his faith in justice in the world.
His expertise (world-class performance) in the field of chemistry, distinguished persons and their letters of congratulation are presented below as a mark of appreciation. It is important to the ongoing international recognition of outstanding achievements through his publications. It also means the authors value him and that he is important to them. Both a high-impact resume and a cover letter on Monster highlight his experience and accomplishments.
Szymon → Jakub → Wladyslaw → Jozef → Jaroslaw Jozef (lineage)
Ancestors (great grandfathers last names and great grandmothers maiden names): Spychala, Bartkowiak, Binias, Kazmierczak, Nitschke, Rybarczyk, Nowicka, and Pawlak.
Jozef Spychala was born in Gora on 17 March 1934, Parents: Wladyslaw Spychala and Zofia Bartkowiak: http://www.ogrodywspomnien.pl/index/showmpl,47 (Sierakow Commune).
https://www.ogrodywspomnien.pl/index/showd/36282?t=112#w (wreath of flowers)
Walentyna Spychala, née Nitschke, Family ID F465 - Polish Roots (polishroots.us).
Family-tree (drzewo genealogiczne) - Jaroslaw Jozef Spychala - Ogrody Wspomnien: http://www.ogrodywspomnien.pl/index/tree/g,7134/graph,d.
Stanislawa Nitschke, née Rybarczyk. Died June 9, 1990. Born September 21, 1900. Parents: Antoni Rybarczyk and Stanislawa Nowicka.
President, InterFACE Ministries (the face of international friendships organization since 1991, cross-cultural friendships and exchange of ideas, www.iface.org, https://www.facebook.com/unclebobculver). Email from bob@iface.org to jjspycha@amu.edu.pl (July 31, 2007, 2:01 pm): ‘It saddens me to see you being taken advantage of in a court of law’. Re: Merry Christmas Wishes, Email from bob@iface.org to jjspychala@wp.pl (December 20, 2018, 4:12 pm): ‘I wish you the same joyous Christmas because of our Savior! Bob Culver «My heart says of you, “Seek his face!” Your face, LORD, I will seek» (Ps 27:8)’. Re: Christmas season arrive, Email from bob@iface.org to jjspychala@wp.pl (December 17, 2019, 4:15 pm): ‘I wish you the same and hope to visit your splendid country on one of our upcoming trips to see our daughter’s family in Budapest. Merry Christmas! Bob Culver, IFace President Emeritus & ACMI Board Chair’.
Emeritus Professor at the University of Wollongong, Arts Faculty, Australia, www.bmartin.cc. He is an author of the book entitled ‘The Whistleblower's Handbook’ (a work of 89 pages). Email from bmartin@uow.edu.au to jjspychala@wp.pl (April 29, 2010, 1:54 am): ‘All I can do is make a few comments and to refer you to a few publications’.
Emeritus, Regents Professor at the Georgia State University, Department of Chemistry, P.O. Box 4098, Atlanta, Georgia 30302-4098, USA. Scopus Author ID 35447594700: 400 publications cited by 5675 documents, 150 coauthors, total citations - 11070 by 5675 documents on 14 June 2018. Website: https://chemistry.gsu.edu/profile/david-w-boykin/. His fax about the Tetrahedron Letters publication: ‘Looks interesting! I would appreciate a reprint when available. Regards, Dave B., 3/15/99’. The Pergamon Press original reprint of the above-mentioned publication was sent to both Dr. Dave Boykin and on request (pc 3/9/00) to Professor Grace Karminski-Zamola from the University of Zagreb (Faculty of Technology, Department of Organic Chemistry, Marulicev trg 20, POB. 177, 10000 Zagreb, Croatia). Facsimile Cover Page, Dean’s Office, College of Arts and Sciences, GSU. Helpful Advice (4/9/97): ‘Dear Jarek, Thanks for the Fax of Ap 4. The structures look interesting. Perhaps you know, but you can directly get novel structures tested via NCI both for many tumor lines and for HIV; they require only 25mg. The NCI accept samples worldwide. They require that you first send drawings of structures before you send compounds. The address of the person that I deal with is below. I hope things are going well with you and I look forward to seeing your paper in Synthetic Communications. Best wishes, David Boykin’. Re: Heterocyclic Communications, Email from dboykin@gsu.edu to jjspycha@amu.edu.pl (November 29, 2005, 0:15 pm): ‘Hello Jarek, I have not been an editor of HC for sometime now. Lucjan is currently an editor and as a consequence I am forwarding your email to him. Best regards, Dave B. Response from Dr. Lucjan Strekowski, Email from lucjan@gsu.edu to jjspycha@amu.edu.pl (November 30, 2005, 1:42 pm): ‘Jarek, The publisher of Heterocyclic Communications has recently introduced page charges in the amount of $100 for two pages, $150 for four pages, and more for more pages. If you still want to submit a manuscript, please contact Editor for European Countries: Professor Jacques Barbe (gerctop@pharmacie.univ-mrs.fr) for additional information. I am editor for North America. Cheers, Lucjan’.
Director General at the International Biographical Centre, St Thomas Place, Ely, Cambridgeshire CB7 4GG, England. Info by letter of 22 May 2018, Ref. DIB39/typ: ‘It gives me great pleasure to enclose a typescript of your entry as it will appear in the Dictionary of International Biography. We are pleased that you are taking your rightful place within its pages. We hope that it will be a fitting tribute to leading personalities throughout the world. Both the Suite of Diplomas and Medal of Inclusion are a tasteful and permanent reminder of your inclusion in a title that will be distributed to libraries and research institutions worldwide’.
Membership Recruitment, American Chemical Society, 1155 Sixteenth Street, NW, Washington, DC 20036, USA. Email from new_member@acs.org to jjspycha@amu.edu.pl (October 5, 2007, 9:24 am): ‘As an ACS journal contributor, I know that you value the American Chemical Society for the vital role it plays in your profession. Now I invite you to discover yet another way that ACS can further your professional career by accepting our invitation to become a member of this prestigious society. ACS membership is the ideal complement to your local or national chemical society membership, providing you with a global view of the chemical industry, interaction with chemical professionals around the world, and tools to help you excel in your field’.
Editor-in-Chief at the Royal Institution of Great Britain, Davy-Faraday Research Laboratory, 21 Albemarle Street, London, W1X 4BS, United Kingdom. Manuscript no: 06/02/01, Email from dawn@ri.ac.uk to jjspycha@amu.edu.pl (February 13, 2006, 2:40 pm): ‘I am pleased to tell you that your manuscript has been accepted for publication in Catalysis Letters as it stands and should be appearing in the journal shortly. A reprint form can be downloaded from the Catalysis Letters (2017 Impact Factor: 2.911) website. Please note, any queries regarding publication dates, etc. should be directed to the Technical Editor in New York’.
Distinguished Professor, Editor-in-Chief, Journal of the American Chemical Society, University of Utah, Department of Chemistry, 315 South 1400 East, RM 2020, Salt Lake City, Utah 84112-0850, USA. Open Letter Read: Disregard and Contempt of the Human Rights. Sent-automatically email from Peter.Stang@jacs.acs.org to jjspychala@wp.pl (June 10, 2010, 0:41 am): ‘Your message was read on Wednesday, June 09, 2010, 6:41:25 PM (GMT-06:00), Central Time (US & Canada)’. Original Message ID: 4c0e5948058a60.03567563@wp.pl, automatic action, final recipient RFC822.
Professor of Anticancer Drug Design and Director of the CR-UK Gene Targeted Drug Design Research Group, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom (www.ulsop.ac.uk). DNA Binding Studies Subject, Info by fax of 14 October 2004: ‘I was recently asked by the Drug Development Committee of the EORTC to carry out some preliminary DNA-binding studies on a compound that your laboratory submitted to the NCI for cytotoxicity evaluation: NSC 710607. The compound appears to have interesting DNA-binding properties, and I would be keen to carry out some further studies with a view to possible publications etc’.
Starks C.P. Coordinator, 11428 Rockville Pike, Suite 309, Rockville, MD 20852, USA (Starks C.P. is a division of Starks Associates, Inc), Compound Acquisition Contractor, National Cancer Institute, Drug Discovery Program. Info by letter of 20 May 1997: ‘The structures which you recently provided have now been reviewed, and of the nine compounds offered, seven have been selected for evaluation of potential anticancer and AIDS antiviral activity by the National Cancer Institute. If you wish, you may send samples to Dr. Omar Yoder at the NCI Liaison Office in Brussels. Your interest in NCI’s drug discovery program is very much appreciated’.
Chief, Antiviral Evaluation Branch, DTP, DCT, Rm. 837C Executive Plaza North, National Cancer Institute, Bethesda, MD 20892, USA. Info by letter of 20 May 1997: ‘The compounds which you have submitted to the National Cancer Institute have been evaluated for in vitro anti-HIV activity. We appreciate your interest and participation in this national effort to discover drugs effective in the treatment of AIDS. Please feel free to write me if you have any questions about this report or the screening program’.
Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20892, USA. He reported on 18 August 1999: ‘The NCI’s in vitro anti-tumor screen consists of 60 human tumor cell lines against which compounds are tested (http://dtp.nci.gov). Enclosed are the data obtained from this screen on compounds submitted by you. Screening program staffs have reviewed the data and have provided the attached checklist for your information. Also indicated is any further pending action by NCI. If you have any specific questions concerning the enclosed data or the status of your compounds, please contact Dr. Dan Zaharevitz, Chief, Information Technology Branch or Dr. Ven Narayanan, Chief, Drug Synthesis and Chemistry Branch’.
RCI Editor, Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Osaka 599-8531, Japan. Email from anpo@ok.chem.osakafu-u.ac.jp to jjspycha@amu.edu.pl (March 31, 2006, 6:15 pm): ‘How have you been? I hope you are well and able to enjoy warm spring weather. Thank you for sending me an interesting ms through the E-mail of March 26th, 2007. Your ms has been sent out to reviewers. I will contact you when I can receive any comments from the reviewers. Thank you for your submission of your ms to the Res. Chem. Intermed. Best wishes’.
Editor, Professor at the Department of Chemistry, University of Guelph, Guelph, Ontario, Canada N1G 2W1. Receipt of Manuscript #SC01-6-5A, Email from sulfchem@uoguelph.ca to jjspycha@amu.edu.pl (January 17, 2006, 4:00 pm): ‘I am happy to consider this manuscript for publication’. Tentative Acceptance by Three Referees (February 19, 2006, 9:25 pm): ‘I think the paper fulfils the following criteria: a) Scientific merit, b) Significance to the field of sulfur chemistry, and c) Appropriateness for a high quality, international journal. The manuscript can be suited to be published in Journal of Sulfur Chemistry and I recommend it’. Final Acceptance (February 26, 2006, 9:16 pm): ‘Dear Jaroslaw, I am pleased to tell you that I have accepted your paper for publication. Finally I was quite pleased with your use of English, so I ask if you are interested in contributing a review to J. Sulfur Chem.’
Editorial Office, Organic Chemistry Plus. Invitation to Join Editorial Bard, Email from freda.salome@resinstitution.org to jjspychala@wp.pl (June 20, 2018, 2:13 pm): ‘Dear Jaroslaw Spychala, Greetings and good day. This is an invitation from EnPress Publisher LLC., an independent, international publisher located in United States. Recently, we have read your article, «The usefulness of cyclic diamidines with different core-substituents as antitumor agents» published in Bioorganic Chemistry. We consider that this article is of high academic value. Therefore, we would like to invite you to join the Editorial Board of Organic Chemistry Plus, where you may publish your new academic researches and review advanced articles within your research area. Please reply to this email if you are interested in joining the Editorial Board. We would like to cooperate with such an excellent scholar as you. Thank you for reading this letter. If you have any question, please contact us. We look forward to your positive reply. Best regards’.
Editorial Executive, Editorial Office, Trends in Cancer Research. Email sent from publications@researchtrends.net to jjspychala@wp.pl (June 16, 2018, 10:30 pm): ‘Dear Dr. Spychala, J, This is an invitation for original articles or review articles from you/your group for publication in Trends in Cancer Research. If you have articles, either original or review, in planning for publication you are most welcome to send in a brief outline of the topic by email to editor@researchtrends.net. Articles on all aspects of cancer research (Original/short communication/review/mini-review) are welcome. The journal maintains a rapid publication time-line with minimal time lag for ahead-of-print release on the web. Sending in the following details would be helpful: A tentative title of the article, A short abstract, Nature of the article (original or review), The expected date of submission of the manuscript. Looking forward to hearing from you’. Research Trends, Journal Home - Trends in Organic Chemistry: http://www.researchtrends.net/tia/title.asp?id=14, Email sent from publications@researchtrends.net to jjspychala@wp.pl (December 16, 2018, 9:24 pm): ‘Dear Dr. Spychala, J, This is an invitation for original articles or review articles from you/your group for publication in Trends in Organic Chemistry. There are no publication charges for the present-year volume and authors would be allowed Free Space in the journal. Looking forward to hearing from you, Dr. J. Menon’.
Dominican, Mariologian, Dogmatic Theologian, and Musicologist, Vice-Dean, Professor of Theological Sciences from 2014 at the AMU Faculty of Theology in Poznan (CV on Wikipedia.org), Theological Study at Pontificia Università S. Tommaso, Largo Angelicum, 00184 Roma, Italy. Postcard (pc 11/21/93) with all good wishes for Christmas: ‘Jarku! W ostatnich kilku dniach ukończyłem pisanie mojej trzeciej magisterki (nie wiem ile jeszcze ich w moim życiu napiszę). Póki co, jeszcze w starym roku składam Ci najserdeczniejsze życzenia. Niech Ten, który stworzył przebogaty świat materii, z całym zespołem praw i wiązań - które my ludzie na przestrzeni wieków odkrywamy - pozwoli się tobie objawić jako Mądrość odwieczna podczas analizy materii w laboratorium oraz Ten, który przynosi pokój i miłość ludziom - złożony w betlejemskim żłóbku. Brat Bogusław’. Extracts from other cards: ‘Patrząc na Eucharystię dokonywującą się na ołtarzu zbliżamy się do tajemnicy przyjścia Boga na ziemię (at Christmas)’ and ‘Chrystus Eucharystyczny pokarmem dającym Siłę, Moc, Mądrość, Miłość, Nadzieję i Pokój, czyniącym nas zdolnymi do dźwigania Krzyża codzienności (at Easter)’. Congratulations! Letter with Easter Greetings from Rome to Atlanta (1046 Center Street, Atlanta, GA 30318, USA): ‘Drogi Jarku, Gratuluję, że trud i mozół żmudnych poszukiwań zaowocował doktoratem. Gratuluję także, że to czego nauczyłeś się w kraju możesz rozwinąć i pogłębić w laboratoriach amerykańskich. Jeżeli zaś chodzi o mnie, to po święceniach kapłańskich wyjechałem do Włoch, by najpierw poznać język a od października rozpocząć kolejne studia (to już trzecie w moim życiu). Po kilkumiesięcznym pobycie w Genui przyjechałem wreszcie do Rzymu. Mieszkam w klasztorze dominikańskim i studiuję mariologię na Fakultecie Teologicznym „Marianum” prowadzonym przez oo. Serwitów NMP. Mam dużo pracy. W ub. semestrze miałem 6 egzaminów (w ciągu 2 tygodni), w tym będzie ich 10! Na zbliżające się święta Zmartwychwstania Pańskiego życzę obfitych łask naszego Pana Jezusa Chrystusa (Roma, 15.03.92)’. In the picture attached: Friar Boguslaw Kochaniewicz on the way to Pniewy and Duszniki - 38 km daily stretch of road starting from Sierakow, night’s lodging in Sierakow (total walking distance 613 km from Swinoujscie, 500 km from Stettin, and a place of pilgrimage: Czestochowa).
Director of Operations, InterFACE, 1780 Wayland Cir NE, Atlanta, GA 30319-3670, USA. One Dr. Boyce’s Letter of January 6, 1995: ‘It was so nice to get your packet containing the music cassette tape. It is beautiful! I’m sure we will enjoy it for many years to come. It was so nice of you to remember us, but I am concerned that such a tape, including the necessary postage, is very expensive for you [20,000 “somethings?”]. I really enjoy communicated with you, I don’t want it to be a burden. Did you receive any of the e-mail messages I sent? One problem with e-mail is that you are never sure it has arrived! Bob and I really kept our bus busy in December. Dec. 5-9 I took a group from China to North Carolina, then 16-23 was our regular SKI trip. We hired a second bus and took two bus loads to the Florida Christmas Conference (Dec. 27-Jan. 2), where I was the Bible teacher this year. During the conference everyone was saddened by the death in a motor vehicle accident of an international student from Poland! Jon (Janusz Siodlak) had taken several trips with us, and often came to the Friday evening meetings. His roommate, Peter (Piotr Jankowski), flew back to Atlanta from the conference to make arrangements. We praise the Lord that Jon was a believer! Your friend’. Abba Prayer Fellowship, A division of InterFACE Ministries, Inc., Another Letter of February 22, 1994: ‘Dear Jarek, Your note with the newspaper clipping of bison in Poland, and the hazy picture of Mt. Rushmore arrived here recently. I couldn’t believe there were bison in Poland! I wish I could read the article and find out the details. Too bad Mt. Rushmore was so foggy that day. Thanks for staying in touch. Your friend, Everett «…Let us go at once to entreat the Lord and seek the Almighty. I myself am going» (Zech. 8:21b, NIV)’.
Editor-in-Chief, Department of Biological Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, United Kingdom. RE Reminder, Email from pharis@dmu.ac.uk to jjspycha@amu.edu.pl (September 4, 2006, 2:18 pm): ‘Many thanks for your fax message, and now the e-mail message, regarding a manuscript you sent to me for publication in Spectroscopy. For some reason it appears that I did not receive this manuscript or it may have been some how accidentally deleted. At least I cannot find a message from you in my inbox - this could be due to a problem on my side or yours. You can send your manuscript again to me for consideration. Meanwhile, I would like to stress the focus of Journal is now more towards biomedical relevant issues. Hence it is important that in your manuscript the possible biomedical significance of the study is highlighted (please see below some examples of studies where amidine based inhibitors of proteases have been investigated). In the absence of any biological/biomedical relevance it would not be possible to publish the manuscript in Spectroscopy. I look forward to hearing from you. Best wishes. P.I. Haris’. Current Manuscript, Email from pharis@dmu.ac.uk to jjspycha@amu.edu.pl (September 8, 2006, 11:35 am): ‘I think it is important that there is a sentence at the beginning of the abstract that indicates the biological significance of the molecule and the current study. I know that you have added a paragraph in the introduction, but it is the abstract that appears in most databases. I have to insist on this since I am having reject many physical/organic chemistry papers that are not connected biologically or medically important problems. I look forward to seeing a revised Abstract. Manuscript.doc, Email on 12 September 2006: ‘Dear Dr Spychala, Thanks for sending the modified abstract. Please send us the full manuscript in MS Word format. The manuscript will be reviewed this week and we will inform you of the final decision at the least’. Figures.doc, Email on 13 September 2006: ‘Thanks for sending the manuscript - but I did not find the Figures. Please send them as soon as possible’. RE Figures.doc, Email from pharis@dmu.ac.uk to jjspycha@amu.edu.pl (September 18, 2006, 5:06 pm): ‘I am pleased to inform that your manuscript has been accepted for publication in Spectroscopy. You will receive the proofs in due course. Best wishes, Dr P.I. Haris.’
Managing Director, San Francisco Edit, 3 Pine Ridge Way, Mill Valley, CA 94941, USA (www.sfedit.net). Writing Effective Manuscripts, Email from kretchmer@sfedit.net to jjspycha@amu.edu.pl (September 14, 2006, 2:37 am): ‘We are writing to you because we recently read your paper «Correlation between the reactivity and spectroscopic properties of N-substituted secondary thioamides. New intramolecular N• • •H+• • •N binding approach and proton complexes based on thioamide ligation» in Magnetic Resonance in Chemistry. Your paper was listed in the references in a manuscript we were editing, and your email was listed as the corresponding author. We would like to congratulate you on your publication’. Professor Christian Roussel (CASE AGZ, Université Aix-Marseille III, Av. Escadrille Normandie Niemen, F-13397 Marseille Cedex 20, France) made a request for the John Wiley & Sons, Ltd. author’s copy (pc 7/11/05): ‘I should greatly appreciate receiving a reprint of your paper Magn. Reson. Chem. 2003, 41(3), 169-176. Tank you for your courtesy. Sincerely yours’. San Francisco Edit, 1755 Jackson St., Suite 610, San Francisco, CA 94109-2925 US. Happy Holidays from San Francisco Edit, Email from kretchmer@sfedit.net to jjspychala@wp.pl (December 12, 2018, 8:01 am): ‘Warmest wishes for a joyful Holiday Season and a New Year of peace and happiness! Regards, Paul Kretchmer. P.S. We are open during the holidays’.
Editor, Institut für Biochemie und Molekulare Zellbiologie, Universität Wien, Dr. Bohr-Gasse 9, 1030 Wien, Austria. Manuscript Acceptation, Email from fritz.pittner@unvie.ac.at to jjspycha@amu.edu.pl (January 16, 2006, 11:44 am), The Official Letter (Vienna, 16 January 2006): ‘Dear Dr. Spychala, I am pleased to inform you that your manuscript «A convenient way to methylated 2-imidazolines. Syntheses of fluorene and triazine cyclic diamidines» has been accepted for publication in Chemical Monthly. Sincerely yours, Univ. Prof. Dr. F. Pittner (Max F. Perutz Laboratories, University of Vienna, Vienna Biocenter, Department of Biochemistry).’ An Association of Ph.D. Graduate Students from America’s Top 10 Research Universities, Email from editors@journalexperts.com to jjspycha@amu.edu.pl (July 25, 2007, 11:19 pm): ‘One of the graduate students working with American Journal Experts has recently read your article in Monatshefte fur Chemie. He found your paper while reading the literature for his field, and was impressed by the quality of the research and the thought behind your article. Please visit us online to learn more at www.journalexperts.com. We look forward to helping you reach your research and publishing goals. Best Regards’.
Editor-in-Chief, Publisher: ABI, Inc., Releigh, NC, USA, Facsimile: 919-781-8712, Phone: 919-781-8710, ljohnson@abiworldwide.com. Info by letter of November 27, 2002: ‘On behalf of the American Biographical Institute, I am approaching you with an invitation to become a Consulting Editor of the new and modern reference title, The Contemporary Who’s Who 2002/2003 (Who’s Making A Difference). This is an honorary position with the only requirement being to nominate men and women known to you, who you feel warrant inclusion in a major, international reference directory. I would like to add your name to an international delegation of distinguished individuals who will help us compile this directory. Should you choose to help us in this way and accept this responsibility, I will be glad to prepare and send you a certificate, personalized with your name and designation as Consulting Editor. We are looking to you to nominate those who, in your opinion, are also worthy of inclusion. We appreciate any assistance you can offer in our ongoing efforts to compile the world’s best reference sources. Since 1967, the Institute has compiled important volumes that have been studied by individuals, corporations, and public and private libraries worldwide’. Editorial Advisory Board was composed of 11 distinguished members (D.D., J.D., Ph.D., M.D., City Planner - Publisher, Journalist - Society Editor, Historian - Newspaper Editor, Dept. of State - Scientific Research, and Space Exploration Systems Head). Another Inviting Proposition, Bilingual Publishing, Invitation to Join Editorial Board, Email from joanna.service@gmx.us to jjspychala@wp.pl (September 17, 2018, 5:22 pm): ‘I hope you’re having a great week! We recently came across your article «Selective cytostatic and cytotoxic anticancer effects of bisfunctional agents: A strategy for the design of DNA binding agents» in Cancer Letters. It was an impressive read, and given your achievements and insights in the field of Oncology, Bilingual Publishing CO. would like to invite you to join us as an editorial board member of our new international journal, Journal of Oncology Research. We hope that you would consider our invitation. We look forward to hearing from you. Best regards, Editorial Office, Journal of Oncology Research’.
NCI Liaison Office, Avenue E. Mounier 83 Bte 10, B-1200 Brussels, Belgium, Fax +32-2-770 47 54, NCI.LO@eortc.be. European Collaboration, Info by letter of August 13, 2004: ‘This is with reference to our earlier correspondence on the collaboration between the US National Cancer Institute (NCI) and our colleagues from the European Organization for Research and Treatment of Cancer (EORTC) and the British Cancer Research Campaign (CRC) in the development of potential new anticancer compounds. Following your written approval, information on some of your compounds submitted to the NCI in vitro anticancer screening program had been shared with the CRC/EORTC committee, and one or several of these substances were subsequently selected for further evaluation in Europe (NSC 710607). The EORTC Screening & Pharmacology Group (SPG), chaired by Dr. Iduna Fichtner from the Max-Delbrück Centrum in Berlin-Buch, is directly involved in the evaluation of these compounds, and has expressed an interest to exchange expertise in your specific area of research and to discuss potential areas of collaboration. As your compounds were submitted through our Liaison Office, we have been asked to contact you to find out about your potential interest in a direct discussion regarding your compounds with the EORTC/SPG, and how your area of research could possibly fit into their research activities. Also, it was suggested that you might wish to attend one of the SPG’s future meetings (the AACR/EORTC/NCI meeting in Geneva, Tuesday September 28, 2004), to discuss your compound and perhaps give a short presentation. Please let us know as soon as possible whether you wish to attend. We thank you in advance for your consideration of this inquiry. Should you have any queries please do not hesitate to contact us. We look forward to hearing from you. CC: I. Fichtner, SPG/EORTC and A.S. Govaerts, SPG/EORTC’. Two years previously, on 7 March 2002 Acting Head Susanne Radtke sent an invitation to one of the SPG’s future meetings (e.g. in November 2002 in Frankfurt in connection with the EORTC Translational Research meeting): ‘If required, some of the related travel costs could be covered by the SPG. CC: Dr. R.J. Schultz, DS&CB/DTP/DCT/NCI and Dr. I. Fichtner, SPG/EORTC’.
BAM, Unter den Eichen 87, 12205, Berlin, Germany (www.bam.de). Official Invitation, Info by letter of August 28, 1995: ‘As you surely know, the 17. Conference and Workshop on Magnetic Resonance and Structure of Matter will be coming up soon. I am glad about your decision to participate in the Conference and to bring in an active contribution to the Scientific Programme. With great pleasure I may inform you that the Senate of Berlin approved our application for grants. Expenses related to your stay on the territory of the Federal Republic of Germany from September 27 - September 30, 1995 concerning hotel accommodation in double rooms and full board at the Conference & Hotel Centre Gosen will be covered by the sponsor, including a small amount for the coverage of your expenses from the border crossing point to Gosen. Additionally, no conference fee will be charged. Let me thank you once again for contribution to the conference and welcome you in Gosen. I am looking forward to meeting you soon, Yours sincerely, Prof. Dr. A. Zschunke, Chairman and Programme Committee’.
Editorial Office, BioMed Research International, Hindawi Publishing Corporation (http://www.hindawi.com). BMRI: Oncology, Invitation to Submit an Article, Email from bmri.oncology@journals.hindawi.com to jjspychala@wp.pl (February 3, 2014, 0:32 am): ‘Dear Dr. Spychala, I am writing to invite you to submit an article to the Oncology subject area of BioMed Research International which provides a rapid forum for the dissemination of original research articles as well as review articles. The most recent Impact Factor for BioMed Research International is 2.880 according to 2012 Journal Citation Reports released by Thomson Reuters (ISI) in 2013. All submitted manuscripts during February 2014 will not be subject to any Article Processing Charges. BioMed Research International is published using an open access publication model, meaning that all interested readers are able to freely access the journal online at http://www.hindawi.com/journals/bmri/ without the need for a subscription, and authors retain the copyright of their work. The journal has a distinguished Editorial Board with extensive academic qualifications, ensuring that the journal maintains high scientific standards and has a broad international coverage. A current list of the journal’s editors can be found at http://www.hindawi.com/journals/bmri/editors/. Moreover, all published articles will be made available on PubMed Central and indexed in PubMed at the time of publication. Please do not hesitate to contact me if you have any questions about the journal. Best regards, Reem Ali’.
Special Issue "Advances in Cancer Diagnosis" - IJMS (ISSN 1422-0067). Re: Reminder: Call for Papers, Email from williamcscho@gmail.com to jjspychala@wp.pl, FWD to gruetter@mdpi.com (November 15, 2012, 3:00 pm): ‘Dear Dr. Spychala, Thank you for your kind reply. You are keen on medicinal chemistry?and I look forward to your submission to Advances in Cancer Diagnosis. Thank you very much. Best regards, William CS CHO’. Dr. Spychala’s Original Email Sent on November 15, 2012: ‘Manuscript Title (in preparation): «Promising antitumor activity of triazine diamidines in HCT-116 xenografts and hollow fiber assays», Dear Professor Chi-shing Cho, I appreciate very much your invitation. Unfortunately, I cannot meet the deadline. At present I am not in a position to pay the APC as requested in correspondence. That is just the trouble. Please find above the title of my new full research paper (just for Advances in Cancer Diagnosis). I was planning to submit that anyway. You can check out my profile at http://www.iamscientist.com/people/jjspychala (my great problems). I struggle for my very existence. My apologies for not writing sooner but I was waiting till I could say a positive bit of news. Yours sincerely, Jaroslaw Spychala, Ph.D.’
The Internal Medicine Review, Article Submission, Email from lisseth.tovar@internalmedicinereview.org to jjspychala@wp.pl (September 30, 2017, 0:31 am): ‘An article you authored caught my attention and I am hoping to discuss with you publishing a followup to it, or even a review article in an upcoming issue of the Internal Medicine Review. The article was titled «The usefulness of cyclic diamidines with different core-substituents as antitumor agents». I think a new article in this area would be valuable and it would be great if you would consider preparing something. Please let me know if it is okay for me to send along more information about our journal. Would you or maybe one of your students possibly have time to contribute an article this year? Best Regards, Lisseth Tovar, M.D., Senior Editor’.
Novus Biologicals, Pharmaceutical, LLC 8100 Southpark Way #A-8 Littleton, CO, 80120, USA (http://www.novusbio.com/). Congratulations on Your Publication in Cancer Letters, Email from email@novusbio-email.com to jjspychala@wp.pl (June 17, 2010, 5:04 pm): ‘Dear J. Spychala, On behalf of Novus Biologicals, I would like to congratulate you on your recent publication in Cancer Letters. I am sure that the article, «Selective cytostatic and cytotoxic anticancer effects of bisfunctional agents: A strategy for the design of DNA binding agents», will be a valuable contribution to cancer research. We would like to help you stay at the forefront of cancer research. With best wishes, Bryan Tinsley’.
Advisory Board, Regional Editor, Professor at the Department of Chemistry, University of York, Heslington, York YO10 5DD, UK (tet@york.ac.uk). Referee’s Report of 14 Jun 2000 (RT-2000-30232): ‘This manuscript reports work worthy of publication in Tetrahedron, and makes a new contribution to the chemistry of nucleoside analogues. On the other hand, the manuscript as currently presented needs modification. The purpose of Tetrahedron is to publish full accounts of Current Outstanding Achievements in Organic Chemistry. Articles should have a broad appeal and represent New and Useful contributions likely to advance the science’. Info by fax of 18 August 2000 (9:19 am): ‘Your manuscript has been sent to the publishers for typesetting, however before publication the proofs will be forwarded to you directly from the publishers for checking. When you receive the proofs, please modify as stated in your letter, and notify Elsevier direct of changes made. I do hope this information answers your query. Yours sincerely, R.J.K. Taylor’.
Franchise Career Advisor, Franchise Coordinator & Recruiter, 999 Vanderbilt Road, Suite 200, Naples, FL 34108, rick@selectingafranchise.com. Your Resume Subject, Additional Options Available to You, Email from rick1@qikmail.com to jjspychala@wp.pl (December 30, 2018, 1:31 am): ‘We found your information on Monster.com and based on your background and experience we think you are a good fit. We have been hired to recruit individuals who have worked in corporate America and are interested in business ownership. If you've ever thought about business ownership, we can help. Please take a look at the FCA website: http://franchisecareeradvisors.com/business-ownership/?SRC=New_Lead_31. Once there, complete the request form to receive an article on the "Top Fast Growing Franchise Industries". When we receive your information, we will give you a call within 48 hours to discuss the next steps towards business ownership. Best Regards, Rick’.
Medical Research Archives, Writing a Followup Article? Email from phiri_a@keimra.org to jjspychala@wp.pl (December 30, 2018, 8:48 pm): ‘I am trying to reach the lead author of «The usefulness of cyclic diamidines with different core-substituents as antitumor agents». Would that be you? I wanted to discuss the idea of working on a followup paper which would provide more up to date information on this topic. I have volunteered to edit the next few issues of the Medical Research Archives, and am currently in the process of planning the content which each issue will feature. Have you or maybe a colleague continued in this line of research at all? The Medical Research Archives is unique in that it all articles are published both in an open access online edition and a subscription print edition. I am pasting a link below to some of our more recent open access articles on PubMed so you may get a sense of the sort of articles we publish. Might you consider preparing an article during the next couple of months? Sincerely, A. Phiri, M.D.’ Re: Writing a Followup Article, Email from phiri_a@mail.mrajournal.org to jjspychala@wp.pl (January 11, 2019, 3:00 pm): I hope you are enjoying the new year. I noticed that I have not yet heard back from you about this so I am attempting to get in contact with you again. Please give some thought to this. If you are able to contribute an article could you please fill out our Pre-Registration Form? Best Regards, A. Phiri’.
Editorial Board, Editorial Office. Question Regarding Your Paper, Email from editorialoffice@cmrjournal.com to jjspychala@wp.pl (March 5, 2018, 9:41 am): ‘Dear Dr. Spychala, I hope your year is off to a good start. I read the article you wrote entitled «The usefulness of cyclic diamidines with different core-substituents as antitumor agents» and perhaps you could publish a related manuscript for the next issue of the periodical that I edit. The manuscript could be a followup to this previous paper, or on any of your current work. If you would like I can read any of your current work. Are you potentially interested in contributing such an article? All the best, A. Estrada’.
Regional Executive Editor, Professor at the Department of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK, tetlet@man.ac.uk. Reference Number: TETL/1998/847, Title: A General Synthesis of Diaryl Cyclic Diamidines, Referee’s Report of 18 January 1999: ‘Dear Professor Spychala, We have appreciated the opportunity to consider your paper for publication. It has been examined by an independent referee, whose report is enclosed. We shall be pleased to accept your paper to modification as required by the referee and correction of minor grammatical errors indicated. I have retained one copy of your original paper and enclose another copy with this letter. Please submit the revised version in duplicate. Yours sincerely, E. J. Thomas. PS The referee’s point about diastereoisomers is very important and must be addressed. Only if your diamines were single enantiomers single diastereoisomers be obtained’. The Final Decision of 8 February 1999: ‘Your manuscript has been accepted for publication in Tetrahedron Letters. I enclose herewith a reprint form. Would you please send this directly to Ms Eileen Morrell, Senior Publishing Editor - Tetrahedron Publications, Elsevier Science Ltd., The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, England. Yours sincerely, E. J. Thomas’.
Editor-in-Chief, Archives of Applied Medicine. Contributing an Article to the Issue, Email from siozos@mail.aoam.online to jjspychala@wp.pl (February 21, 2019, 1:06 pm): ‘Dear. Dr. Spychala, I am contacting you because your article from a while ago titled «The usefulness of cyclic diamidines with different core-substituents as antitumor agents» caught my interest and I thought it might be interesting to have a similar article or maybe a followup or review published in the Archives of Applied Medicine. I am editing the next few issues of the Archives of Applied Medicine, which is a subscription peer-reviewed journal available in print and online. I am in need of a few more articles for the issue and am hoping you would think about participating as an author’.
Senior Editor, Multidisciplinary Medicine, Medical Research Archives Special Issue. MRA Articles, Aims & Scope, Email from smith@medicine.mra-journal.org to jjspychala@wp.pl (February 21, 2019, 00:22 pm): ‘Dear Dr. Spychala, I am hoping I can get some input from you regarding a theme issue I am planning titled "The Importance of Multidisciplinary Medicine". I am one of the senior editors responsible for selecting the authors for this issue and came across your information on Medline. Could you please take a look at the issue webpage and let me know if you would be willing to contribute to the issue, either as an author or as a reviewer? By commencing this special theme issue, the Medical Research Archives aims to highlight the importance of cross-discipline collaboration in order to bring about innovations in medicine. The focus of the issue will be articles which span multiple scientific disciplines, for example healthcare and economics. By publishing topics which would not typically reach a medical readership yet have direct implications on the medical field, the journal hopes to inspire new ideas and solutions. The journal will consider for publication all multidisciplinary articles which are scientifically valid and are beneficial for a medical audience’. Dunning Letter, Re: Multidisciplinary Medicine, Email from smith@web.mraj.net to jjspychala@wp.pl (February 26, 2019, 00:59 pm): ‘Dear Dr. Spychala, I have not yet heard back from you about this so I am following up in hope that now is a better time for you to consider it. Please give some thought to this. If you are able to contribute an article could you please fill out our Pre-Registration Form? Best Regards, Dr. L. Smith, M.D.’
Managing Editor, Global Drugs and Therapeutics, Kanazawa University, editor.gdt@oatext.com. Drugs & Therapeutics, Resources for Researchers, Email from editor@clinicalopenaccess.com to jjspychala@wp.pl (February 27, 2019, 01:10 pm): ‘Dear Researcher, Greetings!! It’s a great privilege for me to consider you as a potential author and request to contribute a manuscript to our journal. Please submit your manuscript to editor.gdt@oatext.com on or before 10th March 2019. Thus, we would like to hear from you, regarding publishing your project protocol, research/ review/image/Short Communication articles or case reports with us. We need support from eminent scientists like you to take our journal to the next level. Early submissions are provided with Discounts and Membership Offers. Let me know your interest. Regards, John George’.
Senior Editor, SPG BioMed, Eugen-Huber Strasse 12, Zurich, Switzerland, 8048, https://spg.ltd/spg/spg-biomed/. Regarding Your Article, Email from e_padron@j.spgjournals.org to jjspychala@wp.pl (March 12, 2019, 11:54 am): ‘Dear Dr. Spychala, I hope you are enjoying your week so far. I'm writing to your because an article you wrote caught my attention and I thought it might be interesting to explore the possibility of doing a short followup article for an issue of SPG BioMed this year. The article was titled «The usefulness of cyclic diamidines with different core-substituents as antitumor agents». I was wondering if you could tell me more about any continued research you have done in this field. We have a number of theme issues planned and maybe this would fit the scope of one of them. Please share your thoughts on this. Would it be alright for me to send you our registration form? Sincerely, E. Padron’.
Annals of Advances in Chemistry, 2504 Stillwater CT, Flower Mound Texas - 75022, USA, https://www.heighpubs.org/hjc/. The Editorial Office Impressed by Your Research Interest, Email from hjc@hspcorporation.org to jjspychala@wp.pl (March 23, 2019, 11:35 am): ‘Dear Jaroslaw Spychala, We tried earlier, but there is no response from you, we would like to contact you again! In view of your previous contributions and research interests we are contacting you to submit the manuscript which is useful for the growth of the journal. I would like to bring to your kind notice that we are planning to release our Journal's Upcoming Issue. Please submit your valuable manuscript on or before 8th April 2019. We need your support by submitting your valuable manuscripts towards our Journal. It may be Editorial/Clinical Image/Research/Review/Case study/Perspective/Opinion and Commentary articles for our prestigious journal. I welcome you to submit the articles to this email as an attachment. Thank you very much for your great cooperation. Best Regards’.
Senior Editor, Clinical Medicine Review, Copernicus Publishing, 4607 Library Rd Suite 220-1048, Bethel Park, PA 15102, USA, office@copernicuspubishing.com. Re: Journal Article, Email from umana@email.journals-cmr.org to jjspychala@wp.pl (March 27, 2019, 1:06 pm): ‘Please get back to me about this as soon as you can. We are still trying to get a couple more articles to fill the next issue and it would be great if you could contribute. Best Regards, A. Umana’. The former letter of March 22, 2019: ‘Dear Dr. Spychala, I'm writing to you to discuss having an update to your past article «The usefulness of cyclic diamidines with different core-substituents as antitumor agents» featured in an issue of the Clinical Medicine Review. I think this work would likely be of interest to our readers and that it would be nice to see a paper with more recent data if possible. Or if you haven't continued in this exact line of research maybe we could talk about preparing a research article on some of your related work. Could you please think this over and let me know if you are available to draft an article in the next few months or so? Best Regards’.
Technical Recruiter, 215 Ann Arbor Rd. Suite 304, Plymouth, MI 48170, USA, www.infotreeservice.com. Re: Job Opening as Associate Scientist III - R&D (Chemistry), Letter Value: 1047BB6-5AD21 to Jaroslaw Spychala from the Message Center Inbox on Monster.com (February 5, 2019): ‘My name is Maanvi and I am a Team Lead with Info Tree Service. I saw your profile on Monster.com and I am working on a requirement for a client looking for Associate Scientist III - R&D (Chemistry) and the position is in Eugene, Oregon 97402. This job (TMO-REQ-008758) is a pretty good match for your resume. I have listed the Job Description below. Please let me know if this is in line with what you are looking for? If interested, let me know the hourly wage you are looking for. Also, please reply to me with an updated copy of your resume and a good time and number to reach you so that we can talk about it. Thanks & Regards’.
Talent Sourcing & Acquisition via Randstad Sourceright at Merck Group, Utrecht, The Netherlands, Phone: +31203690543. Re: Are you looking for something more out of your career? Letter Value: 106E478-3F6017E to Jaroslaw Spychala from the Message Center Inbox on Monster.com (March 18, 2019): ‘Hi Jaroslaw, Rather than taking your time at work with a phone call, it would be better if I sent you a message. My name is Guy Ruina. I am Sourcer for Merck on behalf of Randstad Sourceright. Which means we search the country looking to help top professionals improve and advance their careers. So it is no accident that we are talking. I’m guessing that you are probably not looking to try something new right now, but I would love to speak to you briefly about opportunities that may be more passionate about than what you are currently doing. For our ever growing French team, we are looking for a French Purchasing Specialist to come and join us in Wroclaw. The native language in our office is English so a good understanding of English is also beneficial. With that in mind, please contact me at guy.ruina@randstadsourceright.com or just reply on this message if you would like to have a short, non-committal conversation. Met vriendelijke groet, Kind regards’.
Assistant Editor, Wuhan EditSprings Technology and Culture Co., Ltd, 2116/E Wuhan Overseas Scholar Business Park, 11 Dongxing Road, WUHAN, P.R.C, https://www.editsprings.com/en//. Invitation from Editorial Office of EditSprings, Email from recruitment@editsprings.com to jjspychala@wp.pl (March 25, 2019, 8:08 am): ‘Dear Dr. Jaroslaw Spychala, We hope this mail finds you in good health & activity. I'm writing today to extend an invitation to you to join EditSprings, where you can make use of your scholarly attainments and English skill for paper editing with payment in your spare time. EditSprings, an academic service provider established in China in 2010, has helped more than 10,000 Chinese researchers to publish their papers in English academic journals. Over 200 scientists, reviewers and editors from famous institutions cross the U.S., Britain, Canada, and so on are working with us to help increasing researchers overcome the language barrier. If you are interested in joining us, please fill up the following registration form and send us your CV. Let us know which areas you would like to choose. Looking forward to hear from you’.
Study Director, The Science Advisory Board, 2111 Wilson Boulevard, Suite 250, Arlington, VA 22201, Phone (office): 703.778.3080 x14, Facsimile: 703.778.3081. Special Opportunity, Email from a.fernandez@scienceboard.net to jjspychala@wp.pl (March 8, 2011, 5:56 pm): ‘Dear Dr. Spychala, The Science Advisory Board wants to get to know you better! So, we're reaching out to you with a special opportunity to participate in a study designed to "take the pulse" of the scientific community. We have contacted you today because we have identified you as an expert in your field, or because you have participated in a study with The Science Advisory Board in the past. On behalf of The Science Advisory Board, I would like to thank you for taking the time to contribute to this study and I look forward to working with you in the future! Best regards, Angela Fernandez’.
World EXPO Center, Dalian Hightech Zone, Dalian, China, sherry@cancercon.com, http://www.bitlifesciences.com/cancer2011/. Oral Presentation Opportunities, Email from michael5@vaccinecon.com to jjspychala@wp.pl (September 16, 2010, 4:00 am): ‘Dear Jaroslaw Spychala, Based upon your great contributions to the study and research on cancer, you are expected to take part in BIT Life Sciences’ 4th World Cancer Congress (WCC) with the theme of Collaborative Actions against Cancer, which will be held from May 22 to May 25, 2011 in Dalian, China. On behalf of the organizing committee, we cordially welcome you to give a speech at Track 4-3: Bioinformatics, Drug Design and Computer Aided Anticancer Drug Discovery. The details about the program are at the bottoms of the letter. Sincerely yours, Ms. Sherry Dong, Organizing Commission of WCC-2011’.
Committee Chair, European Annual Health Summit, Editorial Board [SPG BioMed], Eugen-Huber Strasse 12, Zurich, Switzerland, 8048, conferences@spg.ltd. Re: Speaking as EAHS session? Email from epadron1@euoffice.spgb.email to jjspychala@wp.pl (August 29, 2019, 05:38 pm): ‘Dear Dr. Spychala, Did you get a chance to think about speaking at the European Annual Health Summit? I would be happy to discuss this in more detail with you and answer any questions you may have. The abstract submission deadline has been extended to September 15. Here is the form for submitting an abstract or poster: https://conferences.spg.ltd/eahs/#registration. Would you be interested in speaking at the summit? E. Padron’. Email of August 14, 2019: ‘Dear Dr. Spychala, I hope your August is off to a good start. We are still searching for a couple more people to speak at the European Annual Health Summit in December. If you could find the time to participate it would be greatly appreciated by myself and the summit committee. It is possible to get a reduced registration fee, in addition to hotel accommodation and the option to apply for travel reimbursement. If you need an invitation letter please let me know. The preliminary program is available at https://conferences.spg.ltd/eahs/EAHS_Preliminary_Program.pdf. Please get back to me about this as soon as you can. Sincerely, E. Padron’. Email of July 28, 2019: ‘Dear Dr. Spychala, I'm hoping talk to you about speaking at the European Annual Health Summit (EAHS), which is held in Rome this year on December 14. From your web pages it looks like you have been doing some work which would be of interest to the summit. It would be great if we could discuss your research and think about where it might fit best within the EAHS program. The summit will consist of keynote presentations followed by eight sessions arranged in two tracks. We are still in need of a couple more session chairs so please let me know if this is something you might be interested in. The summit website and brochure are available at https://conferences.spg.ltd/eahs/. May I send you a copy of the preliminary program? Sincerely, E. Padron’.
WCC-2020 Organizing Committee, 13th Annual World Cancer Congress-2020, Lisbon, Portugal, http://www.bitcongress.com/cancer2020/default.asp, vicky@cancercon-congress.com. We welcome you to give a speech at the upcoming congress. Email from betty1@cancercon-2019.com to jjspychala@wp.pl (November 7, 2019, 10:14 pm): ‘Dear Dr. Jaroslaw Spychala, It’s our honor and pleasure to invite you to attend to the Congress "New Idea, New Tech, New Therapy and New Hope" that will be held in Lisbon, Portugal on June 5th-7th, 2020. I cordially invite you to give an oral presentation in Track 1: Basic Research in Oncology. It will be highly appreciated that you could propose one speech proposal with a speech title and a brief (3-5 sentences) summary on your recent work in the area. World Cancer Congress (WCC) has been successfully organized for 12 times in China, Japan, Singapore, Spain and USA over the past few years. WCC provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. More than 4000 world-renowned experts have been invited to attend the WCC. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of cancer patients. WCC-2020 will be again an opportunity for education and update of the treatment of cancers, providing a clear overview for treatment, with a focus on individualized, multidisciplinary approach with the participation of board range of experts. I would ask you to submit your latest research results for presentation. You are also welcome to propose any topic, activity or scientific program you would like to see covered during the conference. Your active contribution will be crucial to the success of the conference and its impact on our global mission to prevent, diagnose and treat major cancer. Together, we will become a stronger voice and global force and will succeed in decreasing the world-wide burden of cancer. We expect your precious comments or suggestions; also your reference to other speakers will be highly appreciated. We look forward to receiving your replies on the following questions: 1. What is the title of your speech? 2. Do you have any suggestions about our program? I look forward to hearing from you and hopefully working with you at the event. Ms. Vicky Zhang’. Email from mandy16@gastrointestinalconference2019.com to jjspychala@wp.pl (January 12, 2020, 02:35 am): ‘On behalf of the organizing committee, we sincerely welcome you to make a brilliant speech about your recent research at WCC-2020 in Lisbon, Portugal during June 5th -7th, 2020. I have sent you an e-mail couple of days ago, but did not get any response from you, thought you might be busy. I am reaching out to you again to see if you’re interested to participate in our event. The conference program with speaker list has already been released online at https://www.bitcongress.com/cancer2020/scientificprogram.asp. If you’re interested, would you please reply with your speech title? I appreciate your time and attention in advance. Thank you so much. I would be appreciated if you may reply to me regarding this issue at your earliest convenience. Once your commitment prevents you to attend, please kindly let us know. Thank you for your attention and support. With best regards! All the best, Sincerely Yours, Ms. Vicky Zhang, Tel: 0086-411-84799606, Fax: 0086-411-84799629’.
Ph.D., M.Sc.
